SAN PEDRO, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have successfully isolated and propagated 11 major cancer stem cells. These Cancer Stems were launched in May 2007 at the AACR meeting in Los Angeles and also in December 2007 at ASCB in Washington DC.